✦ LIBER ✦

Are we ready to use the hepatitis B surface antigen level to guide peginterferon treatment in HBeAg-negative chronic hepatitis B?

✍ Scribed by Henry Lik Yuen Chan

Book ID: 120902093
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 113 KB
Volume: 7
Category: Article
ISSN: 1936-0533
DOI: 10.1007/s12072-012-9385-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response-guided Peginterferon Therapy fo

Response-guided Peginterferon Therapy for HBeAg-positive and HBeAg-negative Chronic Hepatitis B using Hepatitis B Surface Antigen Levels: A Review

✍ Sonneveld, Milan J.; Brouwer, Willem P.; Janssen, Harry L. A. 📂 Article 📅 2014 🏛 Current Science Inc. 🌐 English ⚖ 233 KB

Hepatitis B virus surface antigen levels

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

✍ Maurizia Rossana Brunetto; Francesco Moriconi; Ferruccio Bonino; George K. K. La 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 748 KB

Bristol-Myers Squibb, Gilead, and Novartis. He is also in the speakers' bureau of Schering-Plough. Dr. Lau is on the speakers' bureau of and received grants from Roche and Novartis. Dr. Piratvisuth advises and is on the speakers' bureau of Roche. He advises Novartis and Schering-Plough and is on th

Hepatitis B surface antigen: Relation to

Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B

✍ Emanuel K. Manesis; George V. Papatheodoridis; Dina G. Tiniakos; Emilia S. Hadzi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 711 KB

460 IMPACT OF SEVERE HEPATITIS REACTIVAT

460 IMPACT OF SEVERE HEPATITIS REACTIVATION ON THE KINETICS OF HEPATITIS B SURFACE ANTIGEN LEVELS IN HEPATITIS B E ANTIGEN (HBEAG)-NEGATIVE CHRONIC HEPATITIS B

✍ H.L.Y. Chan; G.L. Wong; A.O. Lo; A.M. Chiim; H.-Y. Chan; K.K. Yiu; S.H. Chu; V.W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

773 SERUM HEPATITIS B SURFACE ANTIGEN LE

773 SERUM HEPATITIS B SURFACE ANTIGEN LEVELS TO GUIDE THE CESSATION OF ENTECAVIR IN HEPATITIS B e ANTIGEN-NEGATIVE CHRONIC HEPATITIS B: AN INTERIM ANALYSIS

✍ Seto, W.-K.; Hui, A.J.; Wong, V.W.-S.; Wong, G.L.-H.; Liu, K.; Lai, C.-L.; Yuen, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Prediction of sustained response to pegi

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen–positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

✍ Milan J. Sonneveld; Vincent Rijckborst; Charles A. B. Boucher; Bettina E. Hansen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegylated interferon (PEG-IFN). We investigated within a large randomized trial whether quantitative HBsAg levels predict response to PEG-IFN in patients with hepatitis B e antigen (HBeAg)-positive chronic